Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4303669

ZOLEDRONIC ACID
💊 Approved Drug
Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
💊 Approved Drug
O.O=P(O)(O)C(O)(Cn1ccnc1)P(=O)(O)O

Basic Information

ChEMBL ID CHEMBL4303669
Name ZOLEDRONIC ACID
Phase Approved
Structure Type MOL
InChI Key FUXFIVRTGHOMSO-UHFFFAOYSA-N
Therapeutic ✓ Yes
Parent Compound CHEMBL924
Active Moiety CHEMBL924

Known Names

Acide zoledronique Acido zoledronico Aclasta AK-156 CGP 42446 CGP-42446 CGP-42446A NSC-721517 Reclast Zerlinda Zoladrona acid mylan Zoledronate hydrate +13 more
38
Targets
104
Activities
3
Assay Types
5
PK Parameters
20
Publications
25
Known Names
20
Indications
1
Mechanisms

Molecular Properties

272.1
MW (Da)
-1.12
ALogP
5
HBA
5
HBD
153.1
PSA (Ų)
0.43
QED
0
Ro5 Violations
4
Rot. Bonds

Drug Information

Molecule Type Small molecule
First Approval 2001
Availability Prescription
Chirality Achiral

Routes of Administration

Parenteral
USAN Year 1996

Extended Properties

Molecular Formula C5H12N2O8P2
MW 290.11
Aromatic Rings 1
Heavy Atoms 16
NP-Likeness -0.56

Mechanism of Action

Mechanism Action Type Target Direct Efficacy
Farnesyl diphosphate synthase inhibitor INHIBITOR Farnesyl pyrophosphate synthase

Indications

Bone Diseases Fractures, Bone Hypercalcemia Multiple Myeloma Neoplasm Metastasis Neoplasm Metastasis Osteitis Deformans Osteitis Deformans Osteoporosis Osteoporosis, Postmenopausal Prostatic Neoplasms Prostatic Neoplasms Prostatic Neoplasms Prostatic Neoplasms Arthritis, Rheumatoid Bone Diseases, Metabolic Bone Neoplasms Breast Neoplasms Breast Neoplasms Carcinoma, Hepatocellular

ATC Classification

M05BA08
zoledronic acid
Level 1: MUSCULO-SKELETAL SYSTEM
Level 2: DRUGS FOR TREATMENT OF BONE DISEASES

Activity Summary

IC50 85 meas. best 9.62
EC50 13 meas. best 6.31
Ki 6 meas. best 10.15

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Farnesyl pyrophosphate synthase
CHEMBL1782
Ki 10.15 8.61 0.1 2
Farnesyl pyrophosphate synthase
CHEMBL1782
IC50 9.62 7.5617 0.2 23
Mus musculus
CHEMBL375
IC50 8.7 6.8967 2.0 3
Farnesyl pyrophosphate synthase
CHEMBL2150832
Ki 8.0 8.0 10.0 1
Farnesyl pyrophosphate synthase
CHEMBL3693
Ki 7.96 7.96 11.0 1
Unchecked
CHEMBL612545
IC50 7.42 6.7867 38.0 6
Carbonic anhydrase 2
CHEMBL205
IC50 7.21 7.21 62.0 2
Carbonic anhydrase 14
CHEMBL3510
IC50 7.04 7.04 92.0 2
Farnesyl pyrophosphate synthase
CHEMBL3693
IC50 6.96 6.96 110.0 1
Geranylgeranyl pyrophosphate synthase BTS1
CHEMBL1075251
Ki 6.58 6.58 260.0 1
Carbonic anhydrase 12
CHEMBL3242
IC50 6.5 6.5 316.0 2
Butyrophilin subfamily 3 member A1
CHEMBL4105758
EC50 6.31 5.14 486.6 4
Geranylgeranyl pyrophosphate synthase BTS1
CHEMBL1075251
IC50 6.18 6.18 660.0 1
HFF
CHEMBL614071
IC50 6.1 5.35 790.0 4
Toxoplasma gondii
CHEMBL612888
EC50 6.08 6.08 840.0 1
Farnesyl diphosphate synthase
CHEMBL1075078
IC50 5.96 5.96 1100.0 1
Geranylgeranyl pyrophosphate synthase
CHEMBL4769
Ki 5.57 5.57 2700.0 1
Dictyostelium discoideum
CHEMBL612373
IC50 5.54 5.54 2900.0 1
Unchecked
CHEMBL612545
EC50 5.27 5.27 5400.0 1
Carbonic anhydrase 9
CHEMBL3594
IC50 5.27 5.27 5323.0 2
NON-PROTEIN TARGET
CHEMBL3879801
EC50 5.19 5.0667 6400.0 3
Toxoplasma gondii
CHEMBL612888
IC50 5.17 5.17 6700.0 1
72 kDa type IV collagenase
CHEMBL333
IC50 5.16 5.16 7000.0 2
J774
CHEMBL614123
IC50 5.11 5.11 7800.0 1
Trypanosoma brucei rhodesiense
CHEMBL612348
IC50 5.07 5.07 8600.0 1
CFPAC-1
CHEMBL613506
IC50 5.0 5.0 10000.0 1
PANC-1
CHEMBL614139
IC50 5.0 5.0 10000.0 1
BXPC-3
CHEMBL614530
IC50 5.0 5.0 10000.0 1
HeLa
CHEMBL399
IC50 5.0 5.0 10000.0 1
SiHa
CHEMBL612542
IC50 5.0 5.0 10000.0 1
Ca-Ski
CHEMBL1075403
IC50 5.0 5.0 10000.0 1
RPMI-8226
CHEMBL614882
EC50 4.96 4.96 11000.0 2
NCI-H460
CHEMBL396
IC50 4.93 4.93 11700.0 1
Entamoeba histolytica
CHEMBL612853
IC50 4.92 4.92 12000.0 2
Matrix metalloproteinase-14
CHEMBL3869
IC50 4.9 4.9 12600.0 1
MIA PaCa-2
CHEMBL614725
EC50 4.87 4.87 13400.0 1
SF-268
CHEMBL613977
IC50 4.84 4.84 14300.0 1
PANC-1
CHEMBL614139
EC50 4.79 4.79 16100.0 1
Neutrophil collagenase
CHEMBL4588
IC50 4.75 4.75 17600.0 1
MCF7
CHEMBL387
IC50 4.64 4.6 23000.0 2
Trypanosoma cruzi
CHEMBL368
IC50 4.46 4.46 35000.0 1
LoVo
CHEMBL614721
IC50 4.46 4.46 34914.0 1
Matrix metalloproteinase-9
CHEMBL321
IC50 4.28 4.28 52000.0 1
NON-PROTEIN TARGET
CHEMBL3879801
IC50 4.22 4.125 60000.0 2
HCT-116
CHEMBL394
IC50 4.21 4.21 61582.0 1
Geranylgeranyl pyrophosphate synthase
CHEMBL4769
IC50 4.01 4.0025 97000.0 4

Pharmacokinetic Data

Parameter Value Units Species
CL 2.2 mL.min-1.kg-1 Homo sapiens
CL 2.2 mL.min-1.kg-1 Homo sapiens
Fu 0.78 - Homo sapiens
MRT 4.5 hr Homo sapiens
T1/2 11.0 hr Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Farnesyl pyrophosphate synthase Ki = 0.07 nM 10.15 Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10... 18327899
Farnesyl pyrophosphate synthase IC50 = 0.2399 nM 9.62 Negative logarithm of inhibitory concentration against bone resorption 12825934
Farnesyl pyrophosphate synthase IC50 = 2.0 nM 8.7 Inhibition of N-terminal His-tagged human FPPS (1 to 353 residues) expressed in ... 31577901
Mus musculus IC50 = 2.0 nM 8.7 Inhibition of bone resorption in the calvaria assay of mouse 12166945
Farnesyl pyrophosphate synthase IC50 = 3.0 nM 8.52 Inhibition of FDPS (unknown origin) 31699606
Farnesyl pyrophosphate synthase IC50 = 3.0 nM 8.52 Allosteric inhibition of human recombinant FPPS using GPP and [3H]IPP as substra... 24911527
Farnesyl pyrophosphate synthase IC50 = 3.0 nM 8.52 Inhibition of recombinant human FPPS expressed in Escherichia coli by scintillat... 21780776
Farnesyl pyrophosphate synthase IC50 = 4.1 nM 8.39 Inhibition of human recombinant FPPS expressed in Escherichia coli BL21 after 10... 18327899
Farnesyl pyrophosphate synthase IC50 = 4.1 nM 8.39 Inhibition of human FPPS expressed in Escherichia coli BL21 (DE3) preincubated f... 34236862
Farnesyl pyrophosphate synthase IC50 = 4.1 nM 8.39 Inhibition of human recombinant N-terminal-His6 tagged FPPS expressed in Escheri... 22390415
Farnesyl pyrophosphate synthase IC50 = 4.1 nM 8.39 Inhibition of human FPP synthase expressed in Escherichia coli BL21 (DE3) 18937434
Farnesyl pyrophosphate synthase IC50 = 4.1 nM 8.39 Inhibition of human FPPS 25630225
Farnesyl pyrophosphate synthase Ki = 10.0 nM 8.0 Inhibition of recombinant Leishmania major FPPS expressed in Escherichia coli BL... 32979487
Farnesyl pyrophosphate synthase Ki = 11.0 nM 7.96 Binding affinity towards Farnesyl diphosphate synthase from leishmania major 15828834
Mus musculus IC50 = 34.0 nM 7.47 In vitro inhibitory concentration against bone resorption in 17 day old fetal mo... 15828834
Unchecked IC50 = 38.0 nM 7.42 Inhibition of Escherichia coli OPPS 17535895
Farnesyl pyrophosphate synthase IC50 = 60.0 nM 7.22 Inhibition of recombinant human C-terminal His6-tagged FPPS expressed in Escheri... 30216851
Carbonic anhydrase 2 IC50 = 62.0 nM 7.21 Inhibition of human recombinant carbonic anhydrase 2 pretreated for 15 mins by s... 24813742
Carbonic anhydrase 2 IC50 = 62.0 nM 7.21 Inhibition of human recombinant carbonic anhydrase 2 preincubated for 15 mins by... 24650641
Unchecked IC50 = 70.0 nM 7.16 Inhibition of Toxoplasma gondii FPPS incubated for 30 mins by scintillation coun... 34894691

Literature References

PubMed DOI Target Context # Activities
22194678 10.1371/journal.pcbi.1002310 Hepatotoxicity 14
33522236 10.1021/acs.jmedchem.0c01292 ADMET 12
33175535 10.1021/acs.jmedchem.0c01201 Mus musculus 10
31725297 10.1021/acs.jmedchem.9b01405 Farnesyl pyrophosphate synthase 8
12166945 10.1021/jm020819i Rattus norvegicus 8
33175535 10.1021/acs.jmedchem.0c01201 ADMET 7
31725297 10.1021/acs.jmedchem.9b01405 PANC-1 6
30216851 10.1016/j.ejmech.2018.08.044 Bone marrow cell 6
30016091 10.1021/acs.jmedchem.8b00886 RPMI-8226 5
18937434 10.1021/jm801003y BT-549 5
18327899 10.1021/jm7015733 Farnesyl pyrophosphate synthase 4
18426954 10.1124/dmd.108.020479 ADMET 4
- 10.6019/CHEMBL4495565 SARS-CoV-2 4
24607589 10.1016/j.ejmech.2014.02.054 NON-PROTEIN TARGET 4
15857119 10.1021/jm040132t HFF 4
30216851 10.1016/j.ejmech.2018.08.044 RAW264.7 4
29457898 10.1021/acs.jmedchem.7b01824 Butyrophilin subfamily 3 member A1 3
22390415 10.1021/jm201657x Farnesyl pyrophosphate synthase 3
22390415 10.1021/jm201657x NON-PROTEIN TARGET 3
31531198 10.1021/acsmedchemlett.9b00153 Butyrophilin subfamily 3 member A1 3

Data from ChEMBL 36 via Core Engine